Jamie Cesanek

Jamie Cesanek, Assistant Web Editor for CURE®, joined the team in March 2021. She graduated from Indiana University Bloomington, where she studied journalism and minored in sociology and French. In her free time, she enjoys hiking, running, or enjoying time with friends and family. Email her at

Exploring the Dynamics of a Male Cancer Caregiver in a Society That Encourages Men to Be Independent

February 17, 2022

In this episode of the “Cancer Horizons” podcast, the founder of Jack’s Caregiver Coalition, a nonprofit organization dedicated to supporting men throughout the caregiving experience, explores the layered sociological factors which can affect men in unique ways when they are supporting a loved one with cancer.

Losing His Wife to Cancer Brought Chris Draft From the NFL to the White House

February 10, 2022

On this episode of the “Cancer Horizons” podcast, former NFL linebacker Chris Draft discusses his wife’s experience with cancer, which led to her untimely death, and describes why advocacy is so important in the cancer world, especially with Cancer Moonshot bringing disparities to the forefront.

Trial for Brain Cancer Immunotherapy Treatment Opens

February 07, 2022

A phase 2b clinical trial evaluating the efficacy and safety of an immunotherapy drug for patients with brain cancer has opened at Roswell Park Comprehensive Cancer Center in Buffalo, New York, with additional plans to be carried out at more than a dozen sites.

Former Mets Player Dies From Cancer, 6 People With Cancer File Lawsuit About Fukushima Nuclear Disaster, and More

February 04, 2022

From the death of a former New York Mets player due to cancer, to a lawsuit against Tokyo Electric Power Company Holdings regarding cancer potentially caused by the 2011 Fukushima nuclear disaster, here’s what’s happening in the cancer landscape this week.

Side Effects From Newer Cervical Cancer Treatments May Seem ‘Daunting’ for Some Patients, But ‘We Will Have a Plan,’ Expert Says

February 03, 2022

With newer treatments like Keytruda (pembrolizumab) approved for patients with cervical cancer, a younger patient population may be concerned about experiencing side effects that interrupt their lives — but if they occur, clinicians will be ready with a plan for management, says an expert from the Uniformed Services University of the Health Sciences.

‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC

January 27, 2022

In this episode of the “Cancer Horizons” podcast, a woman living with colorectal cancer who was diagnosed 14 years ago at age 29 discusses what it was like to be the youngest person in the treatment room, and how she found another community of young survivors.

‘Life Is Never the Same Again’: Cancer Survivors Describe the Most Difficult Elements of Survivorship

January 26, 2022

From mental impacts such as “scanxiety” and post-traumatic stress disorder to difficulties returning to work/dating and long-term physical side effects like memory issues, several cancer survivors shared the hardest part about survivorship.

Cosibelimab Elicits Positive Tumor Response in Patients With Metastatic Skin Cancer Subtype

January 25, 2022

Patients with metastatic cutaneous squamous cell carcinoma achieved promising response rates after treatment with cosibelimab. If approved, drug developers are hoping to offer cosibelimab as a more affordable immunotherapy option for this patient population.

Patients With Cancer Strongly Encouraged to Get COVID-19 Boosters to Protect Against Omicron Variant

January 18, 2022

A booster dose of the COVID-19 mRNA vaccine may provide patients with cancer with a broader and stronger protection against COVID-19 variants like omicron, according to a cancer researcher at The Ohio State University Comprehensive Cancer Center.